Remote Patient Monitoring and Hospital at Home for COVID-19BioIntelliSense Confidential CV Slides...

18
© 2019 BioIntelliSense, Inc. All rights reserved. BioIntelliSense™, BioSticker™, the BioIntelliSense Logo, and the BioSticker shape are trademarks of BioIntelliSense, Inc. CONFIDENTIAL | © 2019 BioIntelliSense, Inc. All rights reserved. BioIntelliSense™, BioSticker™, the BioIntelliSense Logo, and the BioSticker shape are trademarks of BioIntelliSense, Inc. Remote Patient Monitoring and Hospital at Home for COVID-19 March 2020

Transcript of Remote Patient Monitoring and Hospital at Home for COVID-19BioIntelliSense Confidential CV Slides...

Page 1: Remote Patient Monitoring and Hospital at Home for COVID-19BioIntelliSense Confidential CV Slides March 2020 Author: James Mault Created Date: 20200312160655Z ...

© 2019 BioIntelliSense, Inc. All rights reserved.BioIntelliSense™, BioSticker™, the BioIntelliSense Logo, and the BioSticker shape are trademarks of BioIntelliSense, Inc.CONFIDENTIAL |

© 2019 BioIntelliSense, Inc. All rights reserved.BioIntelliSense™, BioSticker™, the BioIntelliSense Logo, and the BioSticker shape are trademarks of BioIntelliSense, Inc.

Remote Patient Monitoring and Hospital at Home for COVID-19

March 2020

Page 2: Remote Patient Monitoring and Hospital at Home for COVID-19BioIntelliSense Confidential CV Slides March 2020 Author: James Mault Created Date: 20200312160655Z ...

© 2019 BioIntelliSense, Inc. All rights reserved.BioIntelliSense™, BioSticker™, the BioIntelliSense Logo, and the BioSticker shape are trademarks of BioIntelliSense, Inc.CONFIDENTIAL |

COVID-19 CDC Guidelines: Active Monitoring• Active monitoring means that the state or local public

health authority assumes responsibility for establishing regular communication with potentially exposed people to assess for the presence of fever, cough, or difficulty breathing.

• For people with high-risk exposures, CDC recommends this communication occurs at least once each day.

• The mode of communication can be determined by the state or local public health authority and may include telephone calls or any electronic or internet-based means of communication.

2

Page 3: Remote Patient Monitoring and Hospital at Home for COVID-19BioIntelliSense Confidential CV Slides March 2020 Author: James Mault Created Date: 20200312160655Z ...

© 2019 BioIntelliSense, Inc. All rights reserved.BioIntelliSense™, BioSticker™, the BioIntelliSense Logo, and the BioSticker shape are trademarks of BioIntelliSense, Inc.CONFIDENTIAL |

COVID-19 CDC Guidelines: Quarantine and Isolation• Quarantine means the separation of a person or group of

people reasonably believed to have been exposed to a communicable disease but not yet symptomatic, from others who have not been so exposed, to prevent the possible spread of the communicable disease

• Isolation means the separation of a person or group of people known or reasonably believed to be infected with a communicable disease and potentially infectious from those who are not infected to prevent spread of the communicable disease. Isolation for public health purposes may be voluntary or compelled by federal, state, or local public health order.

3

Page 4: Remote Patient Monitoring and Hospital at Home for COVID-19BioIntelliSense Confidential CV Slides March 2020 Author: James Mault Created Date: 20200312160655Z ...

© 2019 BioIntelliSense, Inc. All rights reserved.BioIntelliSense™, BioSticker™, the BioIntelliSense Logo, and the BioSticker shape are trademarks of BioIntelliSense, Inc.CONFIDENTIAL |

Page 5: Remote Patient Monitoring and Hospital at Home for COVID-19BioIntelliSense Confidential CV Slides March 2020 Author: James Mault Created Date: 20200312160655Z ...

© 2019 BioIntelliSense, Inc. All rights reserved.BioIntelliSense™, BioSticker™, the BioIntelliSense Logo, and the BioSticker shape are trademarks of BioIntelliSense, Inc.CONFIDENTIAL |

In-Home Remote Patient Monitoring for COVID19• Elderly with complex chronic disease and other

immunocompromised patients (transplants, oncology, etc) are at high-risk for morbidity and mortality associated with COVID-19

• Continuous monitoring of vital signs and symptoms directlyassociated with COVID-19 may enable early detection and interventions that prevent exacerbation and hospitalization of this high-risk population especially those requiring Quarantine (COVID exposure) or Isolation (COVID confirmed)

• “Hospital at Home” via Remote Patient Monitoring (RPM) may enable earlier discharge of patients hospitalized with COVID-19 to expand bed capacity for new COVID-19 patients requiring admission

5

Page 6: Remote Patient Monitoring and Hospital at Home for COVID-19BioIntelliSense Confidential CV Slides March 2020 Author: James Mault Created Date: 20200312160655Z ...

© 2019 BioIntelliSense, Inc. All rights reserved.BioIntelliSense™, BioSticker™, the BioIntelliSense Logo, and the BioSticker shape are trademarks of BioIntelliSense, Inc.CONFIDENTIAL |

Page 7: Remote Patient Monitoring and Hospital at Home for COVID-19BioIntelliSense Confidential CV Slides March 2020 Author: James Mault Created Date: 20200312160655Z ...

© 2019 BioIntelliSense, Inc. All rights reserved.BioIntelliSense™, BioSticker™, the BioIntelliSense Logo, and the BioSticker shape are trademarks of BioIntelliSense, Inc.CONFIDENTIAL |7

Effortless remote data collection

Medical gradeclinical accuracy

Minute to minute heart rate, respiratory rate, temperature, motion, symptoms, biometrics,

and more

Large on-board memory storage

Long lasting battery life (30+ days)

Cost effective continuous health

monitoring

‘Stick it on’ auto on-body detection

Bluetooth wireless data transmission

Page 8: Remote Patient Monitoring and Hospital at Home for COVID-19BioIntelliSense Confidential CV Slides March 2020 Author: James Mault Created Date: 20200312160655Z ...

© 2019 BioIntelliSense, Inc. All rights reserved.BioIntelliSense™, BioSticker™, the BioIntelliSense Logo, and the BioSticker shape are trademarks of BioIntelliSense, Inc.CONFIDENTIAL |

BioSticker Data Services - FDA 510k Cleared

8

SENSORS BIOSIGNALS BIOSIGNATURES

BIOSTICKER

Motion

AVS

TempSleep

Body Position

RespiratoryRate @ Rest

Skin Temperature

Walk/Run

Gait

Identity Management

Resting Heart Rate

Nocturia

Apnea Screen

Fall

Sneezing

Vomiting

Coughing

Page 9: Remote Patient Monitoring and Hospital at Home for COVID-19BioIntelliSense Confidential CV Slides March 2020 Author: James Mault Created Date: 20200312160655Z ...

© 2019 BioIntelliSense, Inc. All rights reserved.BioIntelliSense™, BioSticker™, the BioIntelliSense Logo, and the BioSticker shape are trademarks of BioIntelliSense, Inc.CONFIDENTIAL |

• Bluetooth enabled• Auto-detection of and communication with

BioSticker• Led touch screen and display• 5G Qualcomm cellular connectivity with

built-in ATT data plan• Captures data from multiple patients and

multiple BioSticker devices• Captures data from select third party blood

pressure meters and weight scales (others pending)

9

Page 10: Remote Patient Monitoring and Hospital at Home for COVID-19BioIntelliSense Confidential CV Slides March 2020 Author: James Mault Created Date: 20200312160655Z ...

© 2019 BioIntelliSense, Inc. All rights reserved.BioIntelliSense™, BioSticker™, the BioIntelliSense Logo, and the BioSticker shape are trademarks of BioIntelliSense, Inc.CONFIDENTIAL |

COVID – 19 Symptoms and Monitoring

10

RespiratoryRate @ Rest

Skin Temperature

Coughing

• FDA – cleared multi-parameter vital signs monitor

• Minute to minute temperature, respiratory rate, coughing tracker

• 30 – day continuous battery life• Bluetooth data transmission

• Stick it on and forget it’ auto on-body detection passive data capture ease of use

Page 11: Remote Patient Monitoring and Hospital at Home for COVID-19BioIntelliSense Confidential CV Slides March 2020 Author: James Mault Created Date: 20200312160655Z ...

© 2019 BioIntelliSense, Inc. All rights reserved.BioIntelliSense™, BioSticker™, the BioIntelliSense Logo, and the BioSticker shape are trademarks of BioIntelliSense, Inc.CONFIDENTIAL |

COVID – 19 Symptoms and Monitoring

11

Page 12: Remote Patient Monitoring and Hospital at Home for COVID-19BioIntelliSense Confidential CV Slides March 2020 Author: James Mault Created Date: 20200312160655Z ...

© 2019 BioIntelliSense, Inc. All rights reserved.BioIntelliSense™, BioSticker™, the BioIntelliSense Logo, and the BioSticker shape are trademarks of BioIntelliSense, Inc.CONFIDENTIAL |

COVID – 19 Remote Patient Monitoring

12

• RPM APPLICATIONS + DASHBOARDS• COMMAND CENTER SERVICES• HEALTH PROGRAMS & CARE PLANS

Page 13: Remote Patient Monitoring and Hospital at Home for COVID-19BioIntelliSense Confidential CV Slides March 2020 Author: James Mault Created Date: 20200312160655Z ...

© 2019 BioIntelliSense, Inc. All rights reserved.BioIntelliSense™, BioSticker™, the BioIntelliSense Logo, and the BioSticker shape are trademarks of BioIntelliSense, Inc.CONFIDENTIAL |

COVID – 19 Case Fatality by Age in China

Page 14: Remote Patient Monitoring and Hospital at Home for COVID-19BioIntelliSense Confidential CV Slides March 2020 Author: James Mault Created Date: 20200312160655Z ...

© 2019 BioIntelliSense, Inc. All rights reserved.BioIntelliSense™, BioSticker™, the BioIntelliSense Logo, and the BioSticker shape are trademarks of BioIntelliSense, Inc.CONFIDENTIAL |

RPM for COVID – 19 At – Risk Population

LEVEL 3

LEVEL 2

LEVEL 1

5% of Patients: Patients who meet High Risk criteria also requiring Quarantine (COVID exposure) or Isolation (COVID confirmed)

15% of Patients• Seniors with Complex Chronic Disease• Solid Organ Transplant Patients• Chemotherapy or BMT• Post Hospital Discharge from COVID

80% of Patients

EXTREME RISKPATIENTS

BIOSTICKER HOURLY MONITORING

HIGH RISK PATIENTS

BIOSTICKER TWICE DAILY MONITORING

LOW RISK

COVID-19 Mobile App Survey and Clinical Guidance Tool

Page 15: Remote Patient Monitoring and Hospital at Home for COVID-19BioIntelliSense Confidential CV Slides March 2020 Author: James Mault Created Date: 20200312160655Z ...

© 2019 BioIntelliSense, Inc. All rights reserved.BioIntelliSense™, BioSticker™, the BioIntelliSense Logo, and the BioSticker shape are trademarks of BioIntelliSense, Inc.CONFIDENTIAL |

BioIntelliSense COVID19 In-Home RPM

15

• High Risk Criteria:• Elderly (65+) with Complex Chronic Disease• Solid Organ and Bone-Marrow Transplant Patients• Cancer Patients Undergoing Chemotherapy

• Extreme Risk Criteria:• Patients requiring quarantine (COVID exposure) or isolation (COVID

confirmed) who meet High Risk criteria• Early Discharge “Hospital at Home”

• Early discharge of patients hospitalized with COVID-19 to expand bed capacity for new COVID-19 patients requiring admission

Page 16: Remote Patient Monitoring and Hospital at Home for COVID-19BioIntelliSense Confidential CV Slides March 2020 Author: James Mault Created Date: 20200312160655Z ...

© 2019 BioIntelliSense, Inc. All rights reserved.BioIntelliSense™, BioSticker™, the BioIntelliSense Logo, and the BioSticker shape are trademarks of BioIntelliSense, Inc.CONFIDENTIAL |

UC Health Virtual Care Command Center

16

Page 17: Remote Patient Monitoring and Hospital at Home for COVID-19BioIntelliSense Confidential CV Slides March 2020 Author: James Mault Created Date: 20200312160655Z ...

© 2019 BioIntelliSense, Inc. All rights reserved.BioIntelliSense™, BioSticker™, the BioIntelliSense Logo, and the BioSticker shape are trademarks of BioIntelliSense, Inc.CONFIDENTIAL |

Page 18: Remote Patient Monitoring and Hospital at Home for COVID-19BioIntelliSense Confidential CV Slides March 2020 Author: James Mault Created Date: 20200312160655Z ...

© 2019 BioIntelliSense, Inc. All rights reserved.BioIntelliSense™, BioSticker™, the BioIntelliSense Logo, and the BioSticker shape are trademarks of BioIntelliSense, Inc.CONFIDENTIAL |18